Volume 43, Issue 3, Pages (September 2005)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Hepatic CD141+IFNλ+ DC subset: One against all?
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Reply to: “DCD consensus and futility in liver transplantation”
Volume 41, Issue 3, Pages (September 2004)
Volume 69, Issue 2, Pages (August 2018)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Volume 41, Issue 3, Pages (September 2004)
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Michael Charlton  Clinical Gastroenterology and Hepatology 
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 56, Issue 6, Pages (June 2012)
Chetana Lim, Chady Salloum, Daniel Azoulay
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Immunological techniques in viral hepatitis
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
The use of hemospray in portal hypertensive bleeding; a case series
Volume 49, Issue 1, Pages (July 2008)
Volume 66, Issue 4, Pages (April 2017)
HCV animal models and liver disease
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
U.P. Neumann, M. Biermer, D. Eurich, P. Neuhaus, T. Berg 
Genetics of hepatocellular carcinoma: The next generation
CMI readers' survey Clinical Microbiology and Infection
Reversion of disease manifestations after HCV eradication
PHES: One label, different goods?!
Presentation transcript:

Volume 43, Issue 3, Pages 381-387 (September 2005) Experts' opinions on the role of liver biopsy in HCV infection: A Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.)  Piero Luigi Almasio, Mauro Niero, Donato Angioli, Antonio Ascione, Sergio Gullini, Giorgio Minoli, Nadia C. Oprandi, Giovan Battista Pinzello, Giorgio Verme, Angelo Andriulli  Journal of Hepatology  Volume 43, Issue 3, Pages 381-387 (September 2005) DOI: 10.1016/j.jhep.2005.02.041 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Distribution in percent of number of years since each centre started to perform liver biopsy (lower panel) and number of biopsies executed each year (upper panel). Journal of Hepatology 2005 43, 381-387DOI: (10.1016/j.jhep.2005.02.041) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Motivations in favour (upper panel) or against (lower panel) liver biopsy. Each expert could give more than one answer (round 1). Journal of Hepatology 2005 43, 381-387DOI: (10.1016/j.jhep.2005.02.041) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Distribution in the number of answers in favour (upper panel), against (middle panel) or uncertain (lower panel) for liver biopsy (round 1). Journal of Hepatology 2005 43, 381-387DOI: (10.1016/j.jhep.2005.02.041) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 4 H Index in different clinical cases (0=maximum agreement; 1=maximum disagreement). Journal of Hepatology 2005 43, 381-387DOI: (10.1016/j.jhep.2005.02.041) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 5 H Index in different clinical cases (0= maximum agreement; 1= maximum disagreement) (only experts answering both round one and two are included). Journal of Hepatology 2005 43, 381-387DOI: (10.1016/j.jhep.2005.02.041) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Frequencies of changed and unchanged answers between the first and the second round in 12 clinical cases (only experts answering both round one and two are included). Journal of Hepatology 2005 43, 381-387DOI: (10.1016/j.jhep.2005.02.041) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Percentage of experts who changed opinion between the two rounds or answered ‘neutral’ at least once. Journal of Hepatology 2005 43, 381-387DOI: (10.1016/j.jhep.2005.02.041) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions